Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer
- PMID: 21439938
- PMCID: PMC3246010
- DOI: 10.1016/j.bbrc.2011.03.090
Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer
Abstract
Serum amyloid A (SAA) is an inflammatory protein predominantly bound to high-density lipoprotein in plasma and presumed to play various biological and pathological roles. We previously found that the murine isoform SAA2.2 exists in aqueous solution as a marginally stable hexamer at 4-20°C, but becomes an intrinsically disordered protein at 37°C. Here we show that when urea-denatured SAA2.2 is dialyzed into buffer (pH 8.0, 4°C), it refolds mostly into an octameric species. The octamer transitions to the hexameric structure upon incubation from days to weeks at 4°C, depending on the SAA2.2 concentration. Thermal denaturation of the octamer and hexamer monitored by circular dichroism showed that the octamer is ∼10°C less stable, with a denaturation mid point of ∼22°C. Thus, SAA2.2 becomes kinetically trapped by refolding into a less stable, but more kinetically accessible octameric species. The ability of SAA2.2 to form different oligomeric species in vitro along with its marginal stability, suggest that the structure of SAA might be modulated in vivo to form different biologically relevant species.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Urea-induced denaturation of apolipoprotein serum amyloid A reveals marginal stability of hexamer.Protein Sci. 2005 Jul;14(7):1811-7. doi: 10.1110/ps.051387005. Epub 2005 Jun 3. Protein Sci. 2005. PMID: 15937280 Free PMC article.
-
Effect of zinc, copper, and calcium on the structure and stability of serum amyloid A.Biochemistry. 2007 May 8;46(18):5562-9. doi: 10.1021/bi602629y. Epub 2007 Apr 11. Biochemistry. 2007. PMID: 17425332
-
From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.Amyloid. 2005 Sep;12(3):139-48. doi: 10.1080/13506120500223084. Amyloid. 2005. PMID: 16194868
-
Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A.Adv Exp Med Biol. 2015;855:117-34. doi: 10.1007/978-3-319-17344-3_5. Adv Exp Med Biol. 2015. PMID: 26149928 Review.
-
Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness.Clin Chem Lab Med. 1999 Apr;37(4):381-8. doi: 10.1515/CCLM.1999.063. Clin Chem Lab Med. 1999. PMID: 10369107 Review.
Cited by
-
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunity.Nat Immunol. 2020 Jul;21(7):756-765. doi: 10.1038/s41590-020-0698-1. Epub 2020 Jun 22. Nat Immunol. 2020. PMID: 32572240 Free PMC article.
-
Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection.Elife. 2014 Jul 29;3:e03206. doi: 10.7554/eLife.03206. Elife. 2014. PMID: 25073702 Free PMC article.
-
Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.FEBS Lett. 2016 Mar;590(6):866-79. doi: 10.1002/1873-3468.12116. Epub 2016 Mar 6. FEBS Lett. 2016. PMID: 26918388 Free PMC article.
-
Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands.Front Endocrinol (Lausanne). 2023 Feb 3;14:1119227. doi: 10.3389/fendo.2023.1119227. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36817589 Free PMC article. Review.
-
Interleukin-1β Induces Intracellular Serum Amyloid A1 Expression in Human Coronary Artery Endothelial Cells and Promotes its Intercellular Exchange.Inflammation. 2019 Aug;42(4):1413-1425. doi: 10.1007/s10753-019-01003-3. Inflammation. 2019. PMID: 31011929
References
-
- Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501–523. - PubMed
-
- Aldo-Benson MA, Benson MD. SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol. 1982;128:2390–2392. - PubMed
-
- Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta. 1989;1006:173–178. - PubMed
-
- Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein’s cellular affinity. A clue to serum amyloid A’s principal function. Lab Invest. 1992;66:778–785. - PubMed
-
- Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC, Sipe JD. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res. 1996;37:2109–2116. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous